Rod has over 30 years’ experience in the life science industry across both biotech and large pharma.
He has founded three innovative biopharmaceutical companies. As the CEO he has led VHsquared Ltd, PharmaKodex Ltd and Microscience Plc from scientific concept/start up through growth into clinical R&D businesses, raising equity financing while building enterprise value and steering their subsequent successful acquisitions by US and European biopharmaceutical companies.
Prior to this Rod held senior R&D and Commercial management positions at both Glaxo and SmithKline Beecham, heading up Business Development at Glaxo Welcome in the lead up to the formation of GSK.
He is an experienced non-executive Board director having previously held non exec roles at life science companies TdeltaS Ltd and Auralis Ltd and is a former Board member of the UK BioIndustry Association (BIA).
Rod is a graduate of London University with a B.Sc. in Pharmacology